Trioxacarcins synthesised as a potent anti-cancer agent
11 March 2016 | By Victoria White
Trioxacarcins disrupt the replication of cancer cells by binding and chemically modifying their genetic material...
List view / Grid view
11 March 2016 | By Victoria White
Trioxacarcins disrupt the replication of cancer cells by binding and chemically modifying their genetic material...
10 March 2016 | By Victoria White
These findings from a new study suggest that psaptides could serve as a promising template for the development of treatment options directed against ovarian and maybe other cancers...
10 March 2016 | By Victoria White
Researchers have identified a first step in the design of a new generation of anti-cancer drugs that include an agent to inhibit resistance to their effectiveness...
10 March 2016 | By Victoria White
PhoreMost has entered into an alliance with The Wistar Institute to identify and de-orphan novel targets in cancer, aging and the immune system...
10 March 2016 | By Victoria White
Ipsen and PeptiMimesis have signed a research partnership and a licensing option for the development and marketing of novel therapeutic peptides in oncology...
9 March 2016 | By Victoria White
Researchers from the University of Texas at San Antonio have developed the "in silico" testing system for drugs in the early stage of drug development...
8 March 2016 | By Victoria White
Researchers have shown that CBR-5884 was able to inhibit cell proliferation of breast cancer and melanoma cells lines that overexpress PHGDH...
8 March 2016 | By Victoria White
Turning off BCL-XL with BH3-mimetic drugs killed Legionella-infected cells, allowing the infection to be cleared from the body...
7 March 2016 | By Victoria White
Scientists have provided a deeper insight into how BRCA1 functions in normal breast tissue and how its loss results in breast cancer...
4 March 2016 | By Oxford Global
This upcoming webinars hosted by Oxford Global will provide an insight on Drug Discovery & Antibody Research...
4 March 2016 | By Victoria White
Researchers have found the tools necessary to give immunotherapy the precision guidance that patients with cancer so desperately need...
3 March 2016 | By Victoria White
Combined with chemotherapy, a novel cell-based immunotherapy drastically increased the survival rates of mice afflicted with brain tumours. Almost 50% of the mice were completely cured...
3 March 2016 | By Victoria White
Scientists at the University of Brighton have shown that bacteriophage can treat infections caused by Proteus mirabilis and prevent catheter blockage...
2 March 2016 | By Victoria White
Researchers have discovered that a GSK-J4 can kill acute lymphoblastic leukaemia that involves the TAL-1 gene...
26 February 2016 | By Victoria White
Regen has recently filed two patent applications covering the molecular pathways activated by NR2F6 silencing...